Back

Cardioneuroablation: an alternative to pacing in pediatric patients with bradycardia and syncope

31 March 2025 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Heart and brain interaction Treatment EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Fredy Chipa Ccasani

Sant Joan de Deu Hospital, Esplugues de Llobregat (Spain)

6 More presentations in this session

Presentation thumbnail
Prediction of early and long-term atrial fibrillation in ischemic stroke patients
Doctor J. Hsu (New Taipei City, TW)
Abstract Slides Video
Presentation thumbnail
Association between change in maximum daily atrial fibrillation duration and ischemic stroke among patients with cardiac implantable electronic devices
Doctor G. Peigh (Chicago, US)
Abstract Slides Video
Presentation thumbnail
Risk factor management and cognitive function in patients with atrial fibrillation
Doctor R. Agarwal (Adelaide, AU) Associate Professor R. Mahajan (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
Predicting intracardiac thrombus formations despite continuous oral anticoagulation in atrial fibrillation patients undergoing catheter ablation procedures: a machine learning approach
Ms F. Ratajczak (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Guideline-based education on stroke prevention and rhythm control in atrial fibrillation: A survey in the STEEER-AF study
Miss C. Van Deutekom (Groningen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Heart and brain interaction

The Event

Event poster

EHRA 2025

31 March 2025 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Cardioneuroablation in pediatric patients with cardioinhibitory vasovagal syncope, functional sinus bradycardia or functional advanced atrioventricular block
thumbnail
Congress Presentation
Cardioneuroablation experience for the treatment of vagally-mediated bradyarrhythmias
thumbnail
Congress Presentation
Clinical outcomes of cardioneuroablation: what does the evidence tell us?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources